Ema approves the first two monoclonal anti SARS cov II therapies Ronapreve and Regkirona, recommended for authorization and marketing in the EU. Ronapreve for adults and adolescents from 12 years of age and weighing at least 40 kg. Regkirona for adults with covid at risk of disease worsening.
#Covid #Ema #approves #monoclonal #therapies